Cargando…
High-altitude Pulmonary Hypertension: an Update on Disease Pathogenesis and Management
High-altitude pulmonary hypertension (HAPH) affects individuals residing at altitudes of 2,500 meters and higher. Numerous pathogenic variables play a role in disease inception and progression and include low oxygen concentration in inspired air, vasculopathy, and metabolic abnormalities. Since HAPH...
Autores principales: | Mirrakhimov, Aibek E., Strohl, Kingman P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Open
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4780514/ https://www.ncbi.nlm.nih.gov/pubmed/27014374 http://dx.doi.org/10.2174/1874192401610010019 |
Ejemplares similares
-
Hypercalcemia of Malignancy: An Update on Pathogenesis and Management
por: Mirrakhimov, Aibek E.
Publicado: (2015) -
Human Immunodeficiency Virus and Pulmonary Arterial Hypertension
por: Mirrakhimov, Aibek E., et al.
Publicado: (2013) -
Chronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphony
por: Mirrakhimov, Aibek E
Publicado: (2012) -
Expiratory Peak Flow and Minute Ventilation Are Significantly Increased at High Altitude versus Simulated Altitude in Normobaria
por: Netzer, Nikolaus C., et al.
Publicado: (2022) -
Non drowsy obstructive sleep apnea as a potential cause of resistant hypertension: a case report
por: Mirrakhimov, Aibek E
Publicado: (2012)